| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 97.660 | 169.695 | 267.962 | 924.362 | 1.674.945 | 3.210.648 | 4.658.760 |
| Total Income - EUR | - | - | - | 97.660 | 169.879 | 268.163 | 924.598 | 1.675.350 | 3.211.900 | 4.659.219 |
| Total Expenses - EUR | - | - | - | 95.446 | 167.067 | 247.066 | 837.975 | 1.548.989 | 2.802.289 | 4.193.646 |
| Gross Profit/Loss - EUR | - | - | - | 2.215 | 2.813 | 21.097 | 86.622 | 126.361 | 409.610 | 465.573 |
| Net Profit/Loss - EUR | - | - | - | 1.236 | 1.100 | 18.512 | 78.782 | 108.198 | 352.596 | 391.669 |
| Employees | - | - | - | 1 | 2 | 3 | 5 | 6 | 8 | 13 |
Check the financial reports for the company - Zuzi Vet Farmaxia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 9 | 0 | 0 | 0 | 29.153 | 19.656 | 13.596 |
| Current Assets | - | - | - | 25.238 | 42.690 | 97.768 | 228.227 | 211.796 | 611.504 | 1.015.596 |
| Inventories | - | - | - | 20.318 | 36.997 | 83.839 | 104.730 | 94.591 | 240.146 | 517.201 |
| Receivables | - | - | - | 1.428 | 1.493 | 1.767 | 18.669 | 23.912 | 40.912 | 60.824 |
| Cash | - | - | - | 3.492 | 4.200 | 12.162 | 104.828 | 93.293 | 330.447 | 437.571 |
| Shareholders Funds | - | - | - | 1.279 | 2.354 | 20.821 | 99.141 | 108.246 | 457.943 | 565.606 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 24.003 | 40.821 | 76.947 | 129.085 | 132.718 | 174.944 | 464.103 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Zuzi Vet Farmaxia S.r.l.